Your browser doesn't support javascript.
loading
Sodium-glucose co-transporter-2 inhibitors and susceptibility to COVID-19: A population-based retrospective cohort study.
Sainsbury, Christopher; Wang, Jingya; Gokhale, Krishna; Acosta-Mena, Dionisio; Dhalla, Samir; Byne, Nathan; Chandan, Joht Singh; Anand, Astha; Cooper, Jennifer; Okoth, Kelvin; Subramanian, Anuradhaa; Bangash, Mansoor N; Taverner, Thomas; Hanif, Wasim; Ghosh, Sandip; Narendran, Parth; Cheng, Kar K; Marshall, Tom; Gkoutos, Georgios; Toulis, Konstantinos; Thomas, Neil; Tahrani, Abd; Adderley, Nicola J; Haroon, Shamil; Nirantharakumar, Krishnarajah.
Afiliação
  • Sainsbury C; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Wang J; Department of Diabetes, Gartnavel General Hospital, NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Gokhale K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Acosta-Mena D; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Dhalla S; Cegedim Health Data, Cegedim Rx, London, UK.
  • Byne N; The Health Improvement Network (THIN), London, UK.
  • Chandan JS; Cegedim Health Data, Cegedim Rx, London, UK.
  • Anand A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Cooper J; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Okoth K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Subramanian A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Bangash MN; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Taverner T; Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
  • Hanif W; Department of Critical Care, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Ghosh S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Narendran P; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
  • Cheng KK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
  • Marshall T; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
  • Gkoutos G; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Toulis K; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Thomas N; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Tahrani A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Adderley NJ; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Haroon S; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Nirantharakumar K; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Diabetes Obes Metab ; 23(1): 263-269, 2021 01.
Article em En | MEDLINE | ID: mdl-32991065
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suscetibilidade a Doenças / Inibidores do Transportador 2 de Sódio-Glicose / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suscetibilidade a Doenças / Inibidores do Transportador 2 de Sódio-Glicose / COVID-19 Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article